Stryker Total Assets 2006-2019 | SYK

Stryker total assets from 2006 to 2019. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Stryker total assets for the quarter ending September 30, 2019 were $26.659B, a 20.72% increase year-over-year.
  • Stryker total assets for 2018 were $27.229B, a 22.67% increase from 2017.
  • Stryker total assets for 2017 were $22.197B, a 8.62% increase from 2016.
  • Stryker total assets for 2016 were $20.435B, a 25.96% increase from 2015.
Stryker Annual Total Assets
(Millions of US $)
2018 $27,229
2017 $22,197
2016 $20,435
2015 $16,223
2014 $17,279
2013 $15,743
2012 $13,206
2011 $12,146
2010 $10,895
2009 $9,071
2008 $7,603
2007 $7,354
2006 $5,874
2005 $4,993
Stryker Quarterly Total Assets
(Millions of US $)
Q3 2019 $26,659
Q2 2019 $26,354
Q1 2019 $25,937
Q4 2018 $27,229
Q3 2018 $22,084
Q2 2018 $21,570
Q1 2018 $22,133
Q4 2017 $22,197
Q3 2017 $21,485
Q2 2017 $21,292
Q1 2017 $20,517
Q4 2016 $20,435
Q3 2016 $20,187
Q2 2016 $20,520
Q1 2016 $19,668
Q4 2015 $16,223
Q3 2015 $15,917
Q2 2015 $16,819
Q1 2015 $16,580
Q4 2014 $17,279
Q3 2014 $17,515
Q2 2014 $17,229
Q1 2014 $16,159
Q4 2013 $15,743
Q3 2013 $14,883
Q2 2013 $14,382
Q1 2013 $14,089
Q4 2012 $13,206
Q3 2012 $12,777
Q2 2012 $12,262
Q1 2012 $12,459
Q4 2011 $12,146
Q3 2011 $12,083
Q2 2011 $11,596
Q1 2011 $11,231
Q4 2010 $10,895
Q3 2010 $10,772
Q2 2010 $10,060
Q1 2010 $10,098
Q4 2009 $9,071
Q3 2009 $8,459
Q2 2009 $7,924
Q1 2009 $7,585
Q4 2008 $7,603
Q3 2008 $7,575
Q2 2008 $8,025
Q1 2008 $7,754
Q4 2007 $7,354
Q3 2007 $6,859
Q2 2007 $6,420
Q1 2007 $6,077
Q4 2006 $5,874
Q3 2006 $5,399
Q2 2006 $5,109
Q1 2006 $4,994
Q4 2005 $4,993
Q3 2005 $4,397
Q2 2005 $4,168
Q1 2005 $4,068
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $74.735B $13.601B
Stryker Corporation is one of the world's leading medical technology companies and together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $152.034B 27.73
Medtronic (MDT) Ireland $150.632B 20.81
Boston Scientific (BSX) United States $62.262B 29.39
Baxter (BAX) United States $42.637B 25.85
Essilor Luxottica (ESLOY) France $33.791B 0.00
Zimmer Biomet Holdings (ZBH) United States $30.320B 19.02
Terumo (TRUMY) Japan $26.378B 32.92
Lonza Group Ag (LZAGY) Switzerland $25.349B 0.00
Coloplast (CLPBY) Denmark $25.034B 38.63
ResMed (RMD) United States $21.891B 40.38
Smith & Nephew SNATS (SNN) United Kingdom $19.633B 0.00
Sunny Optical Technology (SNPTF) China $19.217B 0.00
Bio-Rad Laboratories (BIO) United States $10.857B 52.11
Insulet (PODD) United States $10.712B 509.65
William Demant Holdings (WILYY) Denmark $7.626B 0.00
DiaSorin S.p.A (DSRLF) Italy $7.616B 0.00
Perrigo (PRGO) Ireland $7.422B 13.84
Canopy Growth (CGC) Canada $7.365B 0.00
Hill-Rom Holdings (HRC) United States $7.342B 21.65
Haemonetics (HAE) United States $5.938B 40.13
Shandong Weigao Medical Polymer (SHWGF) China $5.472B 0.00
GN STORE NORD (GNNDY) Denmark $5.276B 27.26
NuVasive (NUVA) United States $3.844B 30.27
ICU Medical (ICUI) United States $3.765B 24.54
Neogen (NEOG) United States $3.625B 60.65
GW Pharmaceuticals (GWPH) United Kingdom $3.265B 0.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.174B 0.00
Quidel (QDEL) United States $2.995B 28.42
Aurora Cannabis (ACB) Canada $2.833B 0.00
Agios Pharmaceuticals (AGIO) United States $2.691B 0.00
National Vision Holdings (EYE) United States $2.513B 56.71
Cardiovascular Systems (CSII) United States $1.557B 0.00
Aphria (APHA) $1.326B 0.00
InMode (INMD) Israel $1.245B 0.00
AtriCure (ATRC) United States $1.217B 0.00
VAREX IMAGING (VREX) United States $1.208B 24.20
Phibro Animal Health (PAHC) United States $0.994B 18.61
TG Therapeutics (TGTX) United States $0.935B 0.00
NanoString Technologies (NSTG) United States $0.916B 0.00
Lantheus Holdings (LNTH) United States $0.810B 20.23
Eagle Pharmaceuticals (EGRX) United States $0.809B 30.96
LeMaitre Vascular (LMAT) United States $0.707B 39.75
Quanterix (QTRX) United States $0.698B 0.00
PetIQ (PETQ) United States $0.694B 16.94
Omeros (OMER) United States $0.657B 0.00
HEXO (HEXO) $0.573B 0.00
Cerus (CERS) United States $0.566B 0.00
Surmodics (SRDX) United States $0.549B 57.11
MacroGenics (MGNX) United States $0.505B 0.00
OraSure Technologies (OSUR) United States $0.491B 29.48
Meridian Bioscience (VIVO) United States $0.418B 14.38
Organigram Holdings (OGI) Canada $0.401B 0.00
Utah Medical Products (UTMD) United States $0.395B 28.63
Owens & Minor (OMI) United States $0.387B 14.30
BioLife Solutions (BLFS) United States $0.317B 129.08
Zynex (ZYXI) United States $0.283B 32.04
Neptune Wellness Solutions (NEPT) Canada $0.281B 0.00
Bovie Medical (APYX) United States $0.275B 0.00
United Health Products (UEEC) United States $0.254B 0.00
Vapotherm (VAPO) United States $0.245B 0.00
Viemed Healthcare (VMD) United States $0.239B 25.14
Repro-Med Systems (KRMD) United States $0.234B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.170B 0.00
Liberty Health Sciences (LHSIF) Canada $0.170B 0.00
InfuSystems Holdings (INFU) United States $0.164B 824.00
Female Health (VERU) United States $0.156B 0.00
Rockwell Medical (RMTI) United States $0.145B 0.00
MTech Acquisition (KERN) United States $0.136B 0.00
Fonar (FONR) United States $0.131B 9.20
Cytosorbents (CTSO) United States $0.130B 0.00
Chimerix (CMRX) United States $0.118B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.093B 0.00
United-Guardian (UG) United States $0.091B 23.03
Chembio Diagnostics (CEMI) United States $0.078B 0.00
Nephros (NEPH) United States $0.067B 0.00
MRI Interventions (MRIC) United States $0.062B 0.00
Surface Oncology (SURF) United States $0.050B 0.00
ImmuCell (ICCC) United States $0.038B 0.00
Trinity Biotech (TRIB) Ireland $0.024B 0.00
Senestech (SNES) United States $0.015B 0.00
Valeritas Holdings (VLRX) United States $0.015B 0.00
GUARDION HEALTH (GHSI) United States $0.014B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.012B 0.00
Myomo (MYO) United States $0.008B 0.00
Capricor Therapeutics (CAPR) United States $0.005B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00
Akers Biosciences Inc (AKER) United States $0.002B 0.00